ABSTRACT: Obesity in many species is associated with reduced fertility and increased risk of metabolic disorders and cardiovascular dysfunction in offspring. Equine metabolic syndrome (EMS) is associated with obesity and characterized by insulin resistance, decreased adiponectin, and elevated insulin, leptin, and pro-inflammatory cytokines. These alterations can potentially disrupt follicular development and impair fertility. We hypothesized that mares with EMS have an altered follicular environment when compared to their normal counterparts, affecting gene regulation for follicle and oocyte maturation. Samples were collected from light-horse mares (11 to 27 yr) in a clinical assisted reproductive program. Mares were screened based on phenotype. Insulin sensitivity was determined by using two proxies, the reciprocal of the square root of insulin (RISQI) and the modified insulin-to-glucose ratio (MIRG). Insulin resistant mares (RISQI < 0.32 and MIRG > 5.50) were allocated to the EMS group (n = 8), and the remaining mares were considered normal controls (CON, n = 12). Follicular fluid (FF) and granulosa cells (GC) from preovulatory follicles were aspirated 24 ± 2 h after administration of a GnRH analog (SucroMate, 0.9 to 1.4 mg, i.m.) and hCG (Chorion, 1500 to 2000 IU, i.v.). After an overnight fast, blood was collected on the morning of follicle aspiration to evaluate serum concentrations of insulin, leptin, adiponectin, and inflammatory cytokines. Expression of 32 genes related to metabolism, follicle maturation, and oocyte maturation were assessed in GC. Concentrations of insulin, leptin, adiponectin, and cytokines were highly correlated between serum and FF (P < 0.001). Insulin was lower (P < 0.001) in serum and FF of CON compared to EMS, but leptin and IL1β tended (P = 0.07 and P = 0.10, respectively) to be lower in FF of CON than EMS. Tumor necrosis factor-α in serum and FF was lower (P < 0.07 and P < 0.05, respectively) in CON than EMS. Conversely, adiponectin was higher (P < 0.05) in serum and FF in CON versus EMS. In GC from CON when compared to EMS, gene expression for epiregulin was elevated (P < 0.05) and tissue inhibitor of matrix metalloproteinase-2 tended to be lower (P = 0.09). Our findings demonstrate that the intrafollicular environment in the mare is influenced by metabolic disease, consistent with findings in other species. Influences on follicular development, oocyte maturation, and subsequent offspring by perturbations due to metabolic disease need further study.
INTRODUCTION
Equine metabolic syndrome (EMS) is a clinical condition in horses comprised of obesity and insulin resistance (IR; Johnson, 2002) . In mares, obesity and IR are associated with altered estrous cycles (Sessions et al., 2004) , anovulatory follicles (Vick et al., 2006) , and increased tumor necrosis factor-α (TNFα), IL-1β, and IL-6 (Vick et al., 2007) . The altered adiposity in horses with EMS is associated with elevated insulin (Walsh et al., 2009 ) and leptin and decreased adiponectin in serum (Kearns et al., 2006) .
The metabolic hormones and cytokines associated with EMS are implicated in disruptions in follicular development in other species. Insulin receptors present in oocytes, ovarian stroma, theca, and granulosa cells establish the ovary as a target of insulin (Poretsky and Kalin, 1987) . Administration of exogenous leptin interferes with dominant follicle development and ovulation in rats (Duggal et al., 2000) . Adiponectin decreases insulin-induced steroidogenesis and increases IGF-1-induced proliferation of cultured bovine granulosa cells (Maillard et al., 2010) . Elevated TNFα inhibits ovulation and steroidogenesis in several species (Terranova and Rice, 1997) . Increased IL-1β in follicles from women with premature luteinization compared to normal follicles (Chen et al., 1995) and the stimulatory effect of IL-1β on ovarian biosynthesis of PGE2 and PGF2α in ovarian dispersates from rats (Kokia et al., 1992) indicates a role in ovulation and luteinization. Excess IL-6 has suppressive effects on reproductive function by preventing LH-triggered ovulation, inhibiting estradiol synthesis and aromatase activity in granulosa cells from rats and women (Gosman et al., 2006) .
Minimal work has been done to evaluate the effect of EMS on the follicular milieu in mares. In this study, we tested the hypothesis that mares with EMS have an altered follicular environment when compared to normal mares, resulting in differences in gene regulation for follicle and oocyte maturation.
MATERIALS AND METHODS
All animal procedures were performed in accordance with the Institutional Animal Care and Use Committee at Colorado State University.
Mare Management
Samples were collected with owner permission from 20 nonlactating, light-horse mares between 12 and 27 yr in the clinical program for assisted reproduction at the Equine Reproduction Laboratory at Colorado State University. Mares were housed in individual box stalls with adjacent outdoor runs; mares had free-choice access to water and were fed hay and concentrate according to individual needs. The experiment was conducted in May at 40.5592° N, 105.0781° W.
Mare reproductive tracts were examined using ultrasound per rectum (Aloka SSD, 500V; Aloka Science and Humanity, Wallingford, CT, USA) with a 5-MHz linear transducer. When a growing follicle ≥32 mm and uterine edema were observed during the follicular phase, a GnRH analog (SucroMate, 0.9 to 1.4 mg, i.m., Bioniche Animal Health USA, Athens, GA) and hCG (Chorulon, 1500 were administered to induce follicle maturation. Between 22 and 24 h later, oocytes, granulosa cells, and follicular fluid were collected by ultrasound-guided transvaginal aspirations, as previously described (Carnevale et al., 2000) . For the collection of follicular fluid, the needle was positioned within the central area of the follicular antrum and the sample of follicular fluid was collected before follicular collapse and blood contamination.
Experimental Design
Mares with EMS were screened based on phenotypic characteristics of the syndrome with increased adiposity in specific areas, such as a crest of neck, tail head, shoulder, and mammary gland (Frank et al., 2010) . Normal mares (CON) were matched to EMS based on age, breed, and body type. Before the morning feeding on the day of follicle aspiration, blood was collected into serum tubes (10 mL, Vacutainer, BD, Franklin Lakes, NJ) to determine IR and for protein assays. An additional sample of blood was collected into PAXgene tubes (5 mL, Qiagen, Valencia, CA) for mRNA determination in blood in accordance with the PAXgene blood RNA kit.
Whole blood was allowed to clot for 2 to 4 h at 4°C, centrifuged at 1,500 × g for 10 min, and then frozen at -20°C until analysis. Follicular fluid was centrifuged within 10 min after collection at 1,500 × g for 10 min and saved at -20°C until protein analyses. Granulosa cells collected during aspiration were placed in 600 μL of Buffer RLT (AllPrep RNA/Protein Kit, Qiagen), snap frozen in liquid nitrogen, and stored at -80°C until mRNA and protein isolation. Oocytes were used for clinical procedures and were not used for analysis. Insulin resistance was used to confirm phenotypic classifications using the reciprocal of the square root of insulin [RISQI, 2 /(fasted glucose -30)] and modified insulin-to-glucose ratio [MIRG, ] (Treiber et al., 2005) . The final classifications were mares with normal insulin sensitivity (CON, RISQI ≥ 0.32 and MIRG < 5.50, n = 12) or insulin resistance consistent with equine metabolic syndrome (EMS, RISQI < 0.30 and MIRG > 5.50, n = 8; Table 1 ). a,b Within a row, means without a common superscript differ (P < 0.001).
1 RISQI = reciprocal of the square root of insulin; determines insulin sensitivity. 2 MIRG = modified insulin-to-glucose ratio; determines insulin response.
Real-time Reverse Transcription PCR
Total mRNA and protein was isolated using the AllPrep RNA/Protein Kit according to the manufacturer's protocol. Primers for the genes of interest plus two endogenous reference genes were designed to have an annealing temperature between 60 and 65°C using predicted sequences for the horse or homologous regions from other species (Table 2) . Complementary DNA was generated using the qScript cDNA synthesis kit (Quanta Bioscience, Gaithersburg, MD) with both oligo (dT) and random primers. Real time quantitative PCR (qPCR) was performed using the LightCycler 480 Real-Time PCR System and the LightCycler 480 SYBER Green I Master detection reagents (Roche Applied Science, Indianapolis IN). For each sample, all genes were analyzed simultaneously in duplicate. Negative controls were included on every plate for every primer set. For most genes of interest, 12.5 ng cDNA were used per reaction; however, due to low gene expression in granulosa cells, 50 ng were used for tumor necrosis factor α (TNF), vascular endothelial growth factor receptor 1 (FLT1) and vascular endothelial growth factor receptor 2 (KDR). The qPCR reaction was run at 95° for 5 min, followed by 45 cycles of: 95° for 10 sec, 60°C for 30 sec, 72°C for 30 sec. Products of qPCR were analyzed on an agarose gel with ethidium bromide to confirm specificity based on fragment size. DNA was isolated from the gel (QAIquick PCR Purification Kit, Qiagen) and sequenced 
Oocyte maturation and cumulus expansion AREG 5'-tcctcggctcagcccattat-3' 3'-acaggggagatctcacttcctga-5'
1 INSR = insulin receptor; LEPR = leptin receptor; ADIPOR1 = adiponectin receptor 1 = ADIPOR2 = adiponectin receptor 2; TNF = tumor necrosis factor α (TNFα); IL1B = interleukin 1β; IL6 = interleukin 6; TNFRSF1A = TNFα receptor; IL6ST = glycoprotein 130; IL6R = IL-6 receptor; FSHR = follicle stimulating hormone receptor; LHCGR = luteinizing hormone receptor; PGR = progesterone receptor; CYP19 = aromatase; STAR = steroidogenic acute regulatory protein; AREG = amphiregulin; EREG = epiregulin; TNFAIP6 = TNF-inducible gene 6; PTGS2 = cyclooxygenase-2; VEGFA = vascular endothelial growth factor A; FLT1 = Vascular endothelial growth factor receptor 1; KDR = vascular endothelial growth factor receptor 2; PPARG = Peroxisome proliferator-activated receptor γ; MMP2 = matrix metalloproteinase-2; TIMP1 = tissue inhibitors of metalloproteinase-1; TIMP2 = tissue inhibitors of metalloproteinase-2; PLAU = urokinasetype plasminogen activator; PLAT = tissue-type plasminogen activator; CEBPB = CCAAT/enhancer-binding protein beta; XIAP = X-linked inhibitor of apoptosis protein; TUB = tubulin; GAPDH = glyceraldehyde 3-phosphate dehydrogenase.
to confirm amplification of the genes of interest (DNA Sequencing Facility, University of California-Davis). Data were analyzed by the LightCycler 480 Relative Quantification Software (Roche Applied Science) and normalized to the geometric mean of the two endogenous controls. Melting curves for each sample were analyzed to validate specificity of amplification.
Protein Analysis
Insulin. Insulin concentrations were determined using a validated radioimmunoassay (RIA, Coat-A-Count, Siemens Healthcare, Erlangen, Germany) as previously reported (Powell et al., 2002) . Two samples of serum and follicular fluid were pooled from multiple mares and used as quality controls. For the RIA, a 200-μL aliquot of undiluted serum or follicular fluid was placed in an antibody-coated test tube to which 1 mL of 125 I-insulin was added. Samples were vortexed and allowed to incubate at room temperature overnight. Samples were then decanted, and the tubes counted for 1 min on a γ counter. The intra-assay coefficient of variation of the pooled samples was 8.5% and the limit of detection was 2.4 μIU/mL.
Leptin. Concentrations of leptin were determined according to the manufacturer's protocol using an RIA (Multi-Species Leptin RIA, Millipore Corp, Billerica, MA) previously validated for use in equine serum (Fitzgerald and McManus, 2000) . Briefly, 100 μL of each undiluted sample of serum and follicular fluid and 100 μL of assay buffer containing Guinea Pig IgG were aliquoted into a glass test tube. An equal volume of multispecies leptin antibody was added. After incubation for 24 h at 4°C, 100 μL 125 I-Human leptin was added to the tubes. After an additional incubation for 24 h at 4°C, 1 mL of precipitating reagent, containing Goat anti-Guinea Pig IgG serum, was added and incubated for 20 min at 4°C. The tubes were centrifuged at 2,000 × g for 20 min at 4°C. The supernatant was decanted, and the remaining pellet counted for 1 min on a γ counter. Linearity and parallelism were evaluated during this experiment to validate its use in follicular fluid. Parallelism of the leptin assay kit was established using the leptin standards from the assay kit, and the standards spiked with horse follicular fluid. Linearity under serial dilutions (no dilution, 1/1) was also demonstrated using horse follicular fluid. Due to the low concentration of leptin in the pooled follicular fluid sample, no further dilutions could be detected. In the absence of purified equine leptin, results are expressed as human equivalents of immunoreactive leptin (leptin-HE). The intra-assay coefficient of variation of the assay was 4.7%. The limit of detection for the assay was 1.6 μIU/mL.
Adiponectin. Concentrations of adiponectin were determined according to manufacturer's protocol using an RIA (Human Adiponectin RIA, Millipore Corp) previously validated for use in equine plasma (Kearns et al., 2006) . Briefly, 100 μL of each sample of serum and follicular fluid (diluted 1:50) and 100 μL of assay buffer were aliquoted into a glass test tube. Equal volumes of 125 I-Adiponectin and 100 μL Adiponectin antibody were added. After incubation for 24 h at 4°C, 10 μL of 30% rabbit carrier was added. Then 1 mL of precipitating reagent containing Goat anti-Rabbit IgG serum was added and incubated for 20 min at 4°C. The tubes were then centrifuged at 2000 × g for 20 min at 4°C. The supernatant was decanted and the remaining pellet counted for 1 min on a γ counter. Linearity and parallelism were evaluated during this experiment to validate its use in follicular fluid. Parallelism of the adiponectin assay kit was established using the adiponectin standards from the assay kit and the standards spiked with horse follicular fluid. Linearity under serial dilutions (1:50, 1:100, 1:200, 1:400, 1:800) was also demonstrated using horse follicular fluid. In the absence of purified equine adiponectin, results are expressed as human equivalents of immunoreactive adiponectin (adiponectin-HE). The intra-assay coefficient of variation of the assay was 5.0%, and the limit of detection was 1.0 μIU/mL.
Tumor Necrosis Factor α. Tumor Necrosis Factor α was analyzed using an ELISA previously used for equine serum (Sun et al., 2008) at the University of Georgia. Briefly, 96-well plates (Immulon-4 plate, Thermo Scientific, Rockford, IL) were coated with polyclonal antibody against equine TNFα (PETNFAI, Thermo Scientific, 3 μg/mL) in carbonate buffer (15 mmol Na 2 CO 3 , 35 mmol NaHCO 3 , pH 9.6). After incubation with a BSA blocking buffer for 1 h, the plates were washed three times with PBS containing 0.05% Tween 20 (PBST). Dilutions of recombinant equine TNF standards (RETNFAI, Thermo Scientific) or samples were then added to respective wells, incubated for 2 h at 37°C, and then washed three times with PBST. Biotin-labelled polyclonal antibody (PETNFABI, Thermo Scientific) against equine TNFα was added to each well and incubated for 90 min at 37°C before avidin-HRP (1:5000, horseradish peroxidase) was added. After an additional incubation and five washes with PBST, 2,2'-azinobis(3-ethylbenzthiazoline-6-sulphonic acid; ABTS HRP, Kirkegaard & Perry Laboratories, Gaithersburg, MD) substrate was added to the wells and incubated for 30 min. Plates were evaluated at 405 nm on a BioTek Epoch (Winooski, VT) plate reader.
Interleukin-1β. Interleukin-1β was measured in a commercially available ELISA (Equine IL1β VetSet, Kingfisher Biotech, Inc, St. Paul, MN) at the Colorado State University Equine Orthopedic Laboratory. Briefly, 100 μL of standard or serum and follicular fluid samples (1:2 to 1:10 dilution) were added in duplicate to plates precoated with equine IL1β and incubated at room temperature for 2 h. Following four washes which included wash buffer, 100 μL of detection antibody working solution was added to each well and incubated at room temperature for 1 h. The plate was again washed four times with wash buffer. Streptavidin-HPR was added (100 μL) before incubation for 30 min at room temperature and four washes. To each well, TMB substrate (100 μL) was added and the plate was developed in the dark at room temperature for 30 min before the addition of 100 μL of stop solution. Plates were evaluated at 450 nm absorbance on a Spectramax Plus 384 (Molecular Devices Corporation, Sunnyvale, CA).
Interleukin-6. Interleukin-6 was measured in an ELISA as previously described in equine serum (Burton et al., 2009 ) at the University of Georgia. Polyclonal goat anti-horse IL6 antibody (AF1886, R&D Systems, Inc., Minneapolis, MN, 0.8 μg/mL) in carbonate buffer was used for coating a 96-well ELISA plate (Immulon-4 plate) and incubated overnight at 4°C. After incubation with a BSA blocking buffer (0.5% BSA in 1× PBS) for 30 min, the plates were washed five times with PBST. Two-fold serial dilutions of recombinant equine IL6 standards (1886-EL, R&D Systems), ranging from 50 to 0.78 ng/mL, or samples were then added to respective wells; the plates were incubated for 90 min at room temperature and then washed five times with PBST. Biotinlabeled polyclonal antibody (AF1886, R & D Systems) against equine IL6 was added to each well and incubated for 60 min at room temperature. After three washes with PBST, avidin-HRP (1:5000) was added before incubation for 30 min. After five additional washes, the plates were filled with TMB substrate (R & D Systems) and incubated for 20 min at room temperature, and the reaction was stopped by adding one volume of 0.5 mol H2SO4. Plates were evaluated at 450 and 630 nm absorbance on a BioTek Epoch plate reader.
Statistical Analyses
Data are expressed as mean ± SEM. Of the mares with EMS, five were administered pergolide mesylate for pituitary pars intermedia dysfunction. Concentrations of insulin, leptin, adiponectin, TNFα, IL1β, and IL6 in serum and follicular fluid and all genes analyzed in granulosa cells were compared between mares with EMS that were or were not treated with pergolide mesylate using Student's t test (SigmaPlot 11.2; Systat Software Inc, San Jose, CA). There were no differences in any parameter evaluated; therefore, EMS data includes all mares. Concentrations of insulin, leptin, adiponectin, TNFα, IL1β, and IL6 in serum and follicular fluid were compared between CON and EMS using Student's t test. Not all mares had detectable amounts of TNFα in the serum or follicular fluid; therefore, the limit of detection for the TNFα assay was used for nondetectable values in statistical analyses. The numbers of mares within each group with detectable concentrations of TNFα were analyzed using Fisher's exact test. One CON mare had concentrations of TNFα that was calculated to be an outlier and was therefore dropped from data analysis for TNFα (Grubb's test, α = 0.01, GraphPad Software, La Jolla, CA). Correlations between serum and follicular fluid concentrations were evaluated using a Pearson's Product Moment Correlation. Genes of interest were normalized to the geometric mean of two reference genes (glyceraldehyde 3-phosphate dehydrogenase [GAPDH] and tubulin [TUBA1A]) and expressed as relative gene expression. The relative expressions were log-transformed to normalize the data and evaluated using Student's t test.
RESULTS

Age, Body Condition, and Insulin Sensitivity
There were no differences in age, body condition score, or body weight between groups (Table 1) . However, insulin sensitivity (RISQI) and the response to insulin (MIRG) were different between CON and EMS (P < 0.05; Table 1 ).
Metabolic Hormones
Concentrations of insulin were lower in CON when compared to EMS in serum and follicular fluid (P < 0.001 and P < 0.001, respectively, Fig. 1A ). In serum, concentrations of leptin were similar for CON and EMS; however, leptin tended (P = 0.07) to be lower in the follicular fluid of CON compared to EMS (Fig. 1B) . Concentrations of adiponectin were elevated (P < 0.05) in CON when compared to EMS in serum and follicular fluid (Fig. 1C) . Concentrations of insulin, leptin, and adiponectin were highly correlated in serum and follicular fluid (Table 3) .
Inflammatory Cytokines
In the CON group, only 10 mares had a sufficient volume sample to be analyzed for TNFα. The proportion of mares with detectable concentrations of TNFα was similar for CON and EMS in serum (3/9 and 6/8, P = 0.15); however, fewer CON had detectable concentrations of TNFα in follicular fluid compared to EMS (1/9 and 5/8, respectively, P = 0.05). Concentrations of TNFα for CON tended (P = 0.07) to be lower than EMS in serum and were lower (P < 0.05, Fig. 1D ) in follicular fluid of CON when compared to EMS. Serum concentrations of IL1β were not different (P = 0.31) in CON when compared to EMS, but concentrations tended (P = 0.13) to be lower in the follicular fluid of CON versus EMS (Fig. 1E) . Concentrations of IL6 were not different in EMS when compared to CON in both serum and follicular fluid (P > 0.50; Fig. 1F ). Concentrations of TNFα, IL1β, and IL-6 were highly correlated in serum and follicular fluid (Table 3) .
Gene Expression
In whole blood, gene expression for CON and EMS were similar (P > 0.4) for TNF, IL1B, and IL6. Granulosa cells expressed genes for the receptors of insulin, leptin, adiponectin, TNFα, IL1β and IL6. With two exceptions, gene expression in granulosa cells was similar for CON and EMS (Table 4) . Control mares had elevated (P < 0.05) expression of epiregulin (EREG) when compared to EMS. Expression of tissue inhibitors of metalloproteinase-2 (TIMP2) tended (P = 0.09) to be lower in CON when compared to mares with EMS.
DISCUSSION
The present study demonstrates that systemic diseases such as EMS are reflected in the ovarian follicle milieu. Concentrations of insulin and leptin were elevated in the follicles of mares with EMS, whereas concentrations of adiponectin were lower. Inflammatory cytokines, TNFα and IL-1β, were also elevated in the follicles of mares with EMS when compared to controls. Granulosa cells expressed receptors for insulin, leptin, adiponectin, TNFα, IL1β, and IL-6, indicating that they can potentially respond to signaling from these molecules.
Mares with EMS had elevated insulin in serum compared to CON mares; however, this is expected as the methods used to select mares for the EMS groups were insulin-sensitivity proxies based on circulating insulin concentrations. Results for insulin sensitivity were consistent with the mare phenotypes. However, follicular fluid from EMS had fivefold higher concentrations of insulin than CON mares, indicating an effect of EMS on the follicular environment. Elevated insulin in the follicle could affect follicular function, as insulin stimulates steroidogenesis in vitro (Poretsky and Kalin, 1987) and promotes granulosa cell proliferation and/or DNA synthesis in vitro (Baranao and Hammond, 1984; Spicer et al., 1993) . In mice, addition of insulin to culture medium containing oocyte granulosa cell complexes results in earlier expression of maximum levels of LH receptor and reduces the oocyte's ability to undergo development from the 2-cell to blastocyst stage (Eppig et al., 1998) . When oocytes from the preantral follicles of mice are cultured in a high concentration of insulin for 10 d, the incidence of abnormal chromatin condensation is higher, although oocytes appear normal under light microscopy (Acevedo et al., 2007) . Maternal diabetes in mice results in a higher frequency of spindle defects and chromosome misalignment, and the rate of abnormal chromosome number in ovulated oocytes is increased ). These alterations would have a deleterious effect on embryo competence. The responsiveness to hyperinsulinemia in granulosa cells, cumulus cells, or oocytes from mares with systemic insulin resistance remains to be elucidated. Although exposed to elevated insulin, granulosa cells in mares with EMS may not be as responsive due to insulin resistance. Women with polycystic ovarian syndrome and mice demonstrate decreased glucose uptake in response to insulin in cumulus cells (Purcell et. al., 2012) . However, induced insulin resistance in granulosa cells from pigs in vitro indicates that, although glucose uptake is attenuated, insulin signaling through MAPK is upregulated, which could increase the androgenic potential of these cells (Yan et. al., 2009) . Further study needs to be conducted to determine if the same response is observed in systemic insulin resistance.
In addition to elevated insulin, mares with EMS also tended to have elevated leptin concentrations in their follicles despite normal systemic concentrations. The con- Table 4 . Relative gene expression in granulosa cells from control mares (CON) and mares with equine metabolic syndrome (EMS) Rows in bold indicate genes that were different or tended to be different between CON and EMS. centrations of leptin were similar to previously reported concentrations of leptin in equine follicular fluid (Gastal et. al., 2010; Lange-Consiglio et.al, 2013) . The correlation between serum and follicular fluid concentrations of leptin was stronger (r 2 = 0.85) than previously reported (r 2 = 0.70; Lange-Consiglio et. al., 2013) . Potentially, systemic concentrations of leptin were not different, because mares with EMS in the present study did not have more overall body fat; however, they had increased adiposity in specific areas such as the crest of the neck, tail head, behind the shoulder, and mammary gland (Frank et al., 2010) . Obese mares with elevated systemic leptin have lengthened interovulatory intervals and lengthened luteal phases compared to feed-restricted mares (Vick et al., 2006) . However, the relationship between elevated serum leptin and disturbances in reproduction remains to be elucidated. In mares, leptin and the leptin receptor have been localized to the oocyte by immunocytochemical analysis ((Lange-Consiglio et al., 2013) , and leptin supplementation, of 100 ng/ml in oocyte maturation medium results in improved oocyte maturation and rates of fertilization after intracytoplasmic sperm injection (ICSI; Lange-Consiglio et al., 2009 ). However, the development rate and quality of 8-cell embryos is reduced at the same dose (LangeConsiglio et al., 2009 ). In the studies in vitro, concentrations of leptin were 30-fold higher than we observed in the follicular fluid of normal, control mares and 16-fold higher than mares with EMS; therefore, it is unknown what impact physiological concentrations would have on oocyte maturation and embryo development. Adiponectin was lower in mares with EMS compared with CON. Reduced concentrations of adiponectin could have negative consequences on follicular and oocyte development. Adiponectin receptors (AdipoR1 and AdipoR2) are found in oocytes from cattle (Maillard et al., 2010) and pigs (Chappaz et al., 2008) . In pigs, the addition of adiponectin to in vitro maturation or embryo culture medium increases the rate of embryo development to the blastocyst stage (Chappaz et al., 2008) . In women undergoing in vitro fertilization, higher adiponectin is a better marker of adequate follicular development for in vitro fertilization than body weight or body mass index (Liu et al., 2005) . Further investigation is needed to clarify the role of adiponectin in follicular development and fertility in mares.
Equine metabolic syndrome was associated with a tendency to have elevated systemic concentrations of TNFα, but not with IL-1β or IL-6; however, mRNA expression of these cytokines in whole blood was not different. This is in contrast to previous findings of Vick et al. (2007) that demonstrated elevated gene expression of IL1 and TNF and concentrations of TNFα in obese mares. The disparate findings could be because of differences in body fat composition between mares in the studies. The mares in the study by Vick et al. (2007) had more overall adiposity, whereas CON and EMS in the present study mares had similar BCS and BW. Increased inflammation associated with obesity is also augmented with age (Vick et. al., 2007; Adams et al., 2009) . Our study included mares aged 11 to 27 in both CON and EMS groups; therefore, ageassociated inflammation related to body fat would have been distributed between the groups.
Both TNFα and IL1β were increased in follicular fluid from EMS when compared to CON, indicating elevated inflammation within the follicles of mares with EMS. Increased cytokine concentrations in follicles are associated with many disturbances in follicular development and fertility. TNFα has been demonstrated to inhibit ovulation and steroidogenesis and to induce luteal regression (Terranova and Rice, 1997) . Receptors for TNFα are present in bovine granulosa and theca cells, and when these cells are cultured with recombinant TNFα, estradiol and progesterone synthesis is inhibited (Sakumoto et al., 2003) . Pig oocytes demonstrate a reduction in maturation and an increase in abnormal chromosome alignment and cytoskeletal structure when exposed to elevated TNFα in vitro (Ma et al., 2010) . Concentrations of TNFα within the equine ovarian follicle have not been previously reported, and more research needs to be completed to determine the impact on the oocyte and fertility.
The interleukins are cytokines derived in large part from adipose tissue. Increased body condition score and percent body fat in mares is associated with increased IL1β expression and insulin resistance (Vick et al., 2007) . Previously, IL1β and the IL1β receptor have been demonstrated to be expressed in horse oocytes and cumulus (Martoriati et al., 2002) . Injection of IL1β into equine follicles increases concentrations of progesterone and prostaglandin-F2α and decreases concentrations of 17β-estradiol in follicular fluid after 38 h (Caillaud and Gerard, 2009 ). Inclusion of IL1β in culture medium decreases epidermal growth factor-induced equine oocyte in vitro maturation rates (Caillaud and Gerard, 2009 ). In our study, IL-1β mRNA was present in granulosa cells. In humans, an increased follicular fluid concentration of IL-1β is related to a higher pregnancy rate in healthy women after ICSI, indicating IL-1β could be of prognostic value in determining oocyte competence (Asimakopoulos et al., 2010) . However, increased follicular fluid concentrations of IL-1β are also associated with premature luteinization in women (Chen et al., 1995) which could interfere with the ovulatory process. In mares, serum and follicular fluid concentrations were highly correlated; however, the impact on follicle quality remains to be elucidated. In ganglia cells, IL-1β stimulates cyclooxygenase enzyme production of prostaglandin E2 (Neeb et al., 2011 ) and a similar role may occur in the follicle during the ovulatory process. Disruptions in this process could inhibit normal ovulation by interfering with normal granulosa cell luteinization and the localized inflammation involved in ovulation.
Concentrations of IL-6 were not different between CON and EMS. IL-6 has been demonstrated to be a potent autocrine regulator of ovarian cumulus cell function and expansion and of oocyte competence (Liu et al., 2009) . However, the role of IL-6 within equine follicles and the impact of IL-6 on follicle maturation and oocyte competence remain to be determined.
Gene expression of TIMP2 and EREG were disrupted with EMS. Tissue inhibitor of metalloproteinase-2 is a regulator of matrix metalloproteinase-2 (MMP-2), binds in a 1:1 covalent complex, and is essential to MMP-2 activation at the proper ratio. If TIMP-2 is absent, no complex can be formed, therefore inhibiting activation. Too much TIMP-2 also results in inhibition of MMP-2 activation (Strongin et al., 1995) . The MMP system is critical for tissue remodeling during follicular maturation and ovulation (Curry and Osteen, 2003) . Potentially, TIMPs play a role in follicular maturation beyond that of MMP regulation, as they have multiple functions, including stimulating progesterone synthesis in vitro during the periovulatory period (Berkholtz et al., 2006) , cell proliferation (Hayakawa et al., 1994) , or apoptosis (Talhouk et al., 1992) . Increased expression of TIMP2 has the potential to disrupt the tissue remodeling necessary for ovulation, which could contribute to obesity-related formation of persistent anovulatory follicles (Vick et al., 2006) .
In this study, we found a relationship between a metabolic disorder and expression of EREG. Epiregulin is produced by granulosa cells and mediates oocyte maturation indirectly by acting on cumulus cells, which express the receptor for EREG (Hsieh et al., 2009 ). Expression of EREG by granulosa cells is induced by LH or hCG and functions in oocyte maturation, germinal vesicle breakdown, and cumulus expansion in mural cells (Park et al., 2004) . In vivo mouse studies have demonstrated a requirement for an unexpectedly prolonged signaling of EREG (Panigone et al., 2008) , and EREG knockout mice display a 40% decrease in meiotic re-entry, as well as inhibited gene expression and cumulus expansion (Hsieh et al., 2007) . The reduced EREG expression in mares with EMS could uncouple the timing of follicle and oocyte maturation.
In conclusion, equine metabolic syndrome is associated with changes in the follicular milieu reflective of systemic concentrations of metabolic hormones and cytokines. The ovarian follicle is dynamic with many factors that regulate its function. Disruption of any of the processes could result in failure of ovulation or could impact oocyte quality. The impact of alterations in the follicular environment on subsequent fertility and the resulting offspring is not known. Research is needed to understand the how metabolic disease's impact on follicular milieu alters fertility in horses.
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